206 related articles for article (PubMed ID: 32647130)
41. Selective lowering of synapsins induced by oligomeric α-synuclein exacerbates memory deficits.
Larson ME; Greimel SJ; Amar F; LaCroix M; Boyle G; Sherman MA; Schley H; Miel C; Schneider JA; Kayed R; Benfenati F; Lee MK; Bennett DA; Lesné SE
Proc Natl Acad Sci U S A; 2017 Jun; 114(23):E4648-E4657. PubMed ID: 28533388
[TBL] [Abstract][Full Text] [Related]
42. Oxidative stress-induced posttranslational modifications of alpha-synuclein: specific modification of alpha-synuclein by 4-hydroxy-2-nonenal increases dopaminergic toxicity.
Xiang W; Schlachetzki JC; Helling S; Bussmann JC; Berlinghof M; Schäffer TE; Marcus K; Winkler J; Klucken J; Becker CM
Mol Cell Neurosci; 2013 May; 54():71-83. PubMed ID: 23369945
[TBL] [Abstract][Full Text] [Related]
43. The role of heparan sulfates in protein aggregation and their potential impact on neurodegeneration.
Maïza A; Chantepie S; Vera C; Fifre A; Huynh MB; Stettler O; Ouidja MO; Papy-Garcia D
FEBS Lett; 2018 Dec; 592(23):3806-3818. PubMed ID: 29729013
[TBL] [Abstract][Full Text] [Related]
44. Involvement of Cellular Prion Protein in α-Synuclein Transport in Neurons.
Urrea L; Segura-Feliu M; Masuda-Suzukake M; Hervera A; Pedraz L; García Aznar JM; Vila M; Samitier J; Torrents E; Ferrer I; Gavín R; Hagesawa M; Del Río JA
Mol Neurobiol; 2018 Mar; 55(3):1847-1860. PubMed ID: 28229331
[TBL] [Abstract][Full Text] [Related]
45. 14-3-3 Proteins Reduce Cell-to-Cell Transfer and Propagation of Pathogenic α-Synuclein.
Wang B; Underwood R; Kamath A; Britain C; McFerrin MB; McLean PJ; Volpicelli-Daley LA; Whitaker RH; Placzek WJ; Becker K; Ma J; Yacoubian TA
J Neurosci; 2018 Sep; 38(38):8211-8232. PubMed ID: 30093536
[TBL] [Abstract][Full Text] [Related]
46. Nucleation of α-Synuclein Amyloid Fibrils Induced by Cross-Interaction with β-Hairpin Peptides Derived from Immunoglobulin Light Chains.
Heid LF; Kupreichyk T; Schützmann MP; Schneider W; Stoldt M; Hoyer W
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003322
[TBL] [Abstract][Full Text] [Related]
47. Uncovering the Binding and Specificity of β-Wrapins for Amyloid-β and α-Synuclein.
Orr AA; Wördehoff MM; Hoyer W; Tamamis P
J Phys Chem B; 2016 Dec; 120(50):12781-12794. PubMed ID: 27934063
[TBL] [Abstract][Full Text] [Related]
48. Amyloid oligomerization of the Parkinson's disease related protein α-synuclein impacts on its curvature-membrane sensitivity.
Gallea JI; Ambroggio EE; Vilcaes AA; James NG; Jameson DM; Celej MS
J Neurochem; 2018 Nov; 147(4):541-556. PubMed ID: 30142705
[TBL] [Abstract][Full Text] [Related]
49. Noninvasive bioluminescence imaging of α-synuclein oligomerization in mouse brain using split firefly luciferase reporters.
Aelvoet SA; Ibrahimi A; Macchi F; Gijsbers R; Van den Haute C; Debyser Z; Baekelandt V
J Neurosci; 2014 Dec; 34(49):16518-32. PubMed ID: 25471588
[TBL] [Abstract][Full Text] [Related]
50. Amyloid-Beta Peptides Trigger Aggregation of Alpha-Synuclein In Vitro.
Köppen J; Schulze A; Machner L; Wermann M; Eichentopf R; Guthardt M; Hähnel A; Klehm J; Kriegeskorte MC; Hartlage-Rübsamen M; Morawski M; von Hörsten S; Demuth HU; Roßner S; Schilling S
Molecules; 2020 Jan; 25(3):. PubMed ID: 32013170
[TBL] [Abstract][Full Text] [Related]
51. Exosomal cell-to-cell transmission of alpha synuclein oligomers.
Danzer KM; Kranich LR; Ruf WP; Cagsal-Getkin O; Winslow AR; Zhu L; Vanderburg CR; McLean PJ
Mol Neurodegener; 2012 Aug; 7():42. PubMed ID: 22920859
[TBL] [Abstract][Full Text] [Related]
52. Oligomeropathies and pathogenesis of Alzheimer and Parkinson's diseases.
Forloni G; Artuso V; La Vitola P; Balducci C
Mov Disord; 2016 Jun; 31(6):771-81. PubMed ID: 27030592
[TBL] [Abstract][Full Text] [Related]
53. Intracellular soluble α-synuclein oligomers reduce pyramidal cell excitability.
Kaufmann TJ; Harrison PM; Richardson MJ; Pinheiro TJ; Wall MJ
J Physiol; 2016 May; 594(10):2751-72. PubMed ID: 26915902
[TBL] [Abstract][Full Text] [Related]
54. Crucial role of protein oligomerization in the pathogenesis of Alzheimer's and Parkinson's diseases.
Choi ML; Gandhi S
FEBS J; 2018 Oct; 285(19):3631-3644. PubMed ID: 29924502
[TBL] [Abstract][Full Text] [Related]
55. Amyloid-β Peptide Induces Prion Protein Amyloid Formation: Evidence for Its Widespread Amyloidogenic Effect.
Honda R
Angew Chem Int Ed Engl; 2018 May; 57(21):6086-6089. PubMed ID: 29645399
[TBL] [Abstract][Full Text] [Related]
56. Binding Sites for Amyloid-β Oligomers and Synaptic Toxicity.
Smith LM; Strittmatter SM
Cold Spring Harb Perspect Med; 2017 May; 7(5):. PubMed ID: 27940601
[TBL] [Abstract][Full Text] [Related]
57. Aβ exacerbates α-synuclein-induced neurotoxicity through impaired insulin signaling in α-synuclein-overexpressed human SK-N-MC neuronal cells.
Chang CC; Li HH; Chang YT; Ho YJ; Hsieh LJ; Chiu PY; Cheng YS; Lin CL; Lai TJ
CNS Neurosci Ther; 2018 Jan; 24(1):47-57. PubMed ID: 29092095
[TBL] [Abstract][Full Text] [Related]
58. Esterification of PQQ Enhances Blood-Brain Barrier Permeability and Inhibitory Activity against Amyloidogenic Protein Fibril Formation.
Tsukakoshi K; Yoshida W; Kobayashi M; Kobayashi N; Kim J; Kaku T; Iguchi T; Nagasawa K; Asano R; Ikebukuro K; Sode K
ACS Chem Neurosci; 2018 Dec; 9(12):2898-2903. PubMed ID: 30074759
[TBL] [Abstract][Full Text] [Related]
59. The N-terminus of α-synuclein is essential for both monomeric and oligomeric interactions with membranes.
Lorenzen N; Lemminger L; Pedersen JN; Nielsen SB; Otzen DE
FEBS Lett; 2014 Jan; 588(3):497-502. PubMed ID: 24374342
[TBL] [Abstract][Full Text] [Related]
60. Single-Molecule Characterization of the Interactions between Extracellular Chaperones and Toxic α-Synuclein Oligomers.
Whiten DR; Cox D; Horrocks MH; Taylor CG; De S; Flagmeier P; Tosatto L; Kumita JR; Ecroyd H; Dobson CM; Klenerman D; Wilson MR
Cell Rep; 2018 Jun; 23(12):3492-3500. PubMed ID: 29924993
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
